The funds will be used to support the company's rapid growth and brings its personalized medication management platform to other places.
The interactions feature also includes disclosures when medications have other lifestyle implications, such as interactions with specific foods or alcohol.
Boston's Brigham and Women's Hospital and Evidation Health will test Medisafe's medication adherence app in a randomized control trial of 390 patients.
The new Medisafe iConnect devices, including iCap and iSort, are Bluetooth connected and can work in tandem with Medisafe's software.
Personalized adherence platform will be used to help patients take Nestlé Health Science's IMPACT ADVANCED RECOVERY Specialized Nutrition Drink.
The new, adherence feature is visible alongside patient biometric measurements such as blood pressure, glucose, weight, and so on.
Thanks to the new feature, users will benefit from localized coupons integrated into Medisafe's app for more than 80 percent off list prices.
Medisafe is the award winning, data driven Medication Management Platform created to improve patient engagement and raise medication adherence.
Patients will be able to visualize in real-time how taking medication or missing a dose impacts important biometrics, such as glucose levels and blood pressure.
The company will use the new funds to accelerate growth in the U.S. market, where nearly half of Americans are prescribed at least one medication per day.